Women In Melanoma: AIM’s Latest Success Story
No excerpt…
Women In Melanoma: AIM’s Latest Success Story
No excerpt…
Pediatric Melanoma Day At Moffitt Cancer Center
No excerpt…
Melanoma Education: Progress Report
No excerpt…
Peer to Peer Support For The Melanoma Community
No excerpt…
Turn Your Superbowl Party into a Fundraiser for Melanoma Research
No excerpt…
Melanoma VS The Pandemic: Interactive Round-Table Discussions For Health Care Providers
No excerpt…
Taking Steps To End Melanoma
No excerpt…
Volunteer With AIM at Melanoma Form
No excerpt…
Steps Against Melanoma Volunteer Form
…on their feet for four hours and must be able to lift 20 lbs. AIM at Melanoma is seeking volunteers…
FDA Grants Toripalimab Fast Track Designation for Mucosal Melanoma
…a subtype of melanoma with mucosal origin. Compared with cutaneous melanoma, mucosal melanoma is less responsive to traditional chemotherapy and…
,
,
Recent Posts
Jun. 09, 2026
The FDA Just Approved a New Sunscreen Ingredient— What It Means for Patients with Skin Cancer, Survivors, and the General Public
Jun. 05, 2026
Fifth Annual Evening in Memory of Valerie Guild
Jun. 05, 2026
Results for darovasertib in combination with crizotinib in first line HLA*A2:01-negative metastatic uveal melanoma met the study’s primary objective
Jun. 05, 2026
Encouraging results with anzutresgene autoleucel in patients with uveal melanoma and other melanoma subtypes
Jun. 05, 2026